Cardiol Therapeutics Files 6-K, Reports for October 2024
Ticker: CRDL · Form: 6-K · Filed: Oct 22, 2024 · CIK: 1702123
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Cardiol Therapeutics (CRDL) filed a 6-K for Oct 2024, confirming 20-F filing.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on October 22, 2024, reporting for the month of October 2024. The company, based in Oakville, Ontario, Canada, is involved in the biological products sector. This filing indicates they will be filing their annual reports under Form 20-F.
Why It Matters
This filing provides an update on Cardiol Therapeutics' reporting status and confirms their adherence to SEC regulations for foreign private issuers, which is important for investors tracking the company's compliance.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) confirming reporting status and not announcing significant new financial or operational developments.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- October 2024 (date) — Reporting period
- 20241022 (date) — Filing date
- Oakville, Ontario, Canada (location) — Company headquarters
- Form 20-F (document) — Annual report filing type
- Form 6-K (document) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer submitted for the month of October 2024, indicating the company's ongoing reporting obligations and confirming the filing of Exhibit 99.1, a news release.
Which annual report form will Cardiol Therapeutics Inc. be filing?
Cardiol Therapeutics Inc. will be filing its annual reports under cover of Form 20-F.
Where is Cardiol Therapeutics Inc. located?
Cardiol Therapeutics Inc. is located at 602-2265 Upper Middle Road East, Oakville, Ontario, Canada.
What is the Commission File Number for Cardiol Therapeutics Inc.?
The Commission File Number for Cardiol Therapeutics Inc. is 001-40712.
What is the SIC code for Cardiol Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Cardiol Therapeutics Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 221 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-10-22 06:31:42
Filing Documents
- form6k.htm (6-K) — 6KB
- exhibit99-1.htm (EX-99.1) — 15KB
- exhibit99-1xu001.jpg (GRAPHIC) — 7KB
- 0001062993-24-017827.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CARDIOL THERAPEUTICS INC. (Registrant) Date: October 22, 2024 By: /s/ Chris Waddick Chris Waddick Title: Chief Financial Officer